We have determined IL-10 promoter genotypes of five single-nucleotide polymorphisms (SNPs): TÀ3575A, AÀ2849G, CÀ2763A, -AÀ1082G and CÀ819T. The haplotype frequencies were defined in healthy subjects compared to leprosy patients, and analyzed for their occurrence in multi-(MB) vs paucibacillary (PB) as severe and mild forms of leprosy, respectively. Haplotypes defined by three SNP positions (À3575, À2849 and À2763) captured significant differences between controls and patients (P ¼ 0.04). The haplotype carrying À3575A, À2849G and À2763C was associated with resistance to leprosy and to the development of severe forms of the disease using either a binomial (controls vs cases, P ¼ 0.005, OR ¼ 0.35, CI ¼ 0.13-0.91) or ordinal (controls vs PB vs MB, P ¼ 0.006, OR ¼ 0.32, CI ¼ 0.12-0.83) model. By contrast, the IL-10 haplotype À3575T/ À2849A/À2763C was found to be associated with susceptibility to leprosy per se (P ¼ 0.027, OR ¼ 2.37, CI ¼ 1.04-5.39), but not leprosy type. The data suggest that the IL-10 locus contributes to the outcome of leprosy.
Introduction
Leprosy is a chronic infectious disease, which is caused by Mycobacterium leprae, and is characterized by a long incubation period. Household contacts of multibacillary (MB) patients are at the highest risk to acquire the disease. 1 Host susceptibility to disease and to specific disease manifestations, notably severe (MB) or mild (paucibacillary (BP)) leprosy, is influenced by both host genetic and environmental factors. 2, 3 Several genomic regions have been implicated in genetically controlled susceptibility to and severity of leprosy. 4 In spite of the strong association of chromosome 6q25-encoded parkin and the parkin coregulated gene with leprosy susceptibility, 5, 6 most likely there are many other regions that influence the outcome of leprosy in its different stages. 7 Among the candidate genes involved in host-pathogen interactions, cytokines evidently play a critical role. 8 Interleukin-10 (IL-10) is a cytokine that seems to be involved in regulating protective immunity in leprosy. A higher tumor necrosis factor-a (TNF-a)/IL-10 ratio was correlated with a better prognosis in terms of clinical outcome of leprosy household contacts. 9 Besides, it has been suggested that IL-10 is enhanced in the MB form of the disease. 10 The IL-10 gene is located on chromosome 1q32 and microsatellites and single nucleotide polymorphisms (SNPs) are arranged to form haplotypes that are associated with levels of IL-10 production. 11, 12 Distal and proximal IL-10 promoter regions can regulate IL-10 secretion differentially, depending on the study reported. [11] [12] [13] [14] In order to assess whether the IL-10 locus influences susceptibility to leprosy or leprosy type, we have compared the frequency of SNPs (À3575, À2849, À2763, À1082 and À819) in the IL-10 locus in leprosy patients and healthy individuals.
Results and discussion
IL-10 promoter SNP alleles in leprosy patients and healthy individuals In order to identify possible IL-10 promoter SNP associated with susceptibility to leprosy per se, or with disease progression and severity, we compared leprosy patients to controls, and also compared PB to MB leprosy patients. Although, the allelic frequencies of leprosy patients (especially MB vs PB) and healthy controls show some variations in frequencies among the groups, the statistical analysis using a weighted logistic regression did not demonstrate any marked differences (Table 1) .
IL-10 haplotype definition and association with disease We next studied haplotypes constructed using three SNPs, given the data that haplotypes formed by the three distal SNPs dictate IL-10 production. A scan to check if any 3 Â 3 combination resulted in a different haplotypic frequency that yielded a difference between cases and controls ( Table 2 ) was performed. In fact, the À3575, À2849 and À2763 SNPs showed that haplotype frequencies were differently distributed between cases and controls (P corrected for sex and ethnicity P c ¼ 0.044). Since the overall differences for haplotype frequencies were significant when controls vs patients were compared, we further studied which haplotype was contributing to leprosy susceptibility and severity in this haplotype arrangement. We used an expectation-maximization (EM) algorithm to calculate the haplotype frequencies, and posterior generalized linear models (GLMs) for binomial (cases vs controls) and ordinal (control vs PB vs MB) traits. The haplotype À3575A/À2849G/À2763C was found to be significantly more frequent among controls than affected cases (simulated P c ¼ 0.005; OR ¼ 0.35, CI ¼ 0.14-0.90) as analyzed using the binomial trait (Table 3 ). This was further confirmed and extended through the ordinal trait analysis where the frequency for the À3575A/À2849G/À2763C haplotype was found to decrease in frequency from controls 4PB 4MB (P c ¼ 0.006; OR ¼ 0.32, CI ¼ 0.13-0.83; Table 4 ). The analysis using the binomial trait, in addition, revealed that the À3575T/À2849A/À2763C haplotype exhibited an increased frequency among patients when compared to controls (simulated P c ¼ 0.027; OR ¼ 2.53, CI ¼ 1.04-6.71), although when using the ordinal trait the À3575T/ À2849A/À2763C haplotype was only of borderline significance (P c ¼ 0.058; OR ¼ 1.88, CI ¼ 0.96-3.69).
The analysis of the entire region encompassing À4 to À0.8 kb using all the data available from the typing of five IL-10 promoter SNPs suggests that the extended protective haplotype would be À3575A/À2849G/ À2763C/À1082G/À819C (P c ¼ 0.024), while À3575T/ À2849A/À2763C/À1082G/À819T (P c ¼ 0.035) is the susceptible haplotype.
We have identified novel markers in the proximal IL-10 promoter that are associated in a way with leprosy susceptibility and severity. The IL-10 haplotype À3575A/ À2849G/À2763C is associated with resistance to leprosy per se, and to the development of severe types of leprosy. By contrast, À3575T/À2849A/À2763C, which is a haplotype detected only in African descents, 10 is associated with susceptibility but not severity of leprosy.
Our recent study of proximal IL-10 SNPs showed an increased frequency of À819TT in leprosy patients as compared to controls 16 in a different set of 300 patients and 100 healthy individuals. In this work, we extended the study population and the region of the IL-10 promoter. In spite of the crude analysis (without correction for covariates) of the À819 SNP allelic frequency comparing cases and controls leading to similar results (not shown), the correction for covariates does not associate À819T allele with leprosy susceptibility (Table 1) . Our data also suggest that the previous associated SNP (À819T) forms an extended haplotype at the distal promoter region (À3575T/À2849A/À2763C/ À1082G/À819T) that is associated to susceptibility in the same direction as the previous results. Thus, the present study confirmed the findings, 16 suggesting that the IL-10 promoter region is participating in controlling suscept- A total of 297 patients were involved in this study. Patients from Leprosy Out-Patient Unit at the Oswaldo Cruz Institute (Rio de Janeiro, Brazil) were classified on the basis of clinical and histological criteria. 15 They were defined on the basis of their bacteriological index (BI) as paucibacillary (PB, n ¼ 131) and multibacillary (MB, n ¼ 166). There were 104 females and 197 males. All patients were treated according to World Health Organization specifications. A total of 283 healthy individuals from the same geographic area (Rio de Janeiro) were involved in the study (185 females and 110 males). Written informed consent was obtained from all individuals included in the study as approved protocol by the local ethical committee (CEP-FIOCRUZ). DNA extraction and IL-10 promoter polymorphism detection were performed using PCR amplification and restriction analysis (PCR-RFLP) as described previously. 16, 17 To analyze the genotypic and allelic frequencies of isolated IL-10 SNPs in patients vs controls or MB vs PB, we used weighted logistic regression models with correction for sex and ethnicity. Haplotype analyses were performed using a 3 Â 3 scan in order to see which region would yield the highest signal with respect to disease association, and then that region was studied in more depth. Tests of association for the scan (overall differences between cases and controls) were performed as described by Schaid et al.
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ibility to and severity of leprosy and the results implicate the À3575T/À2849A/À2763C/À1082G/À819T haplotype with susceptibility although the three distal SNPs were sufficient to capture the information. Recent findings have defined other genomic regions (6q25 and 17q11À21) associated with leprosy susceptibility. 5, 6, 21 The À3575A/À2849G/À2763C or À3575T/À2849A/ À2763C haplotype is a minor haplotype in the different populations studied, 11, 12 and occurs at relatively low frequencies among patients and controls also among Brazilians and Dutch. 17 This suggests that its overall contribution to disease resistance at the population level is limited, which means that the results need replication in other populations to confirm the findings. Actually, it has been suggested that the implication of physiologically relevant SNP haplotypes needs large sample populations with low P-values and independent replication of the results using other populations or data sets. 22 Nevertheless, À3575A/À2849G/À2763C represents a strong disease resistance marker with a role in two different stages, leprosy per se and leprosy type, and may thus provide further genetic insights into the processes that control leprosy susceptibility and disease progression. Unfortunately, the rarity of the associated haplotypes limited the conclusions of the study, although these results suggest that this region deserves attention both in genetics and functional studies to corroborate the findings.
Our results suggest that IL-10 is important during both early and late phases of immunity to M. leprae, but probably plays different roles in these different stages. As mentioned earlier, only a small proportion of the leprosy patients possess the IL-10 haplotypes associated with disease or disease severity, and some patients still carry the leprosy resistance-associated haplotype, indicating that the outcome of mycobacterial disease is due to complex interactions between several host genes, likely including other cytokine genes and receptors, HLA-encoded genes (including TNF-a) and others. 2, 5, 6, 21 Furthermore, it cannot be excluded that the genetic control of susceptibility to leprosy is heterogeneous such that different loci could control the same phenotype. Our Haplotype score tests were calculated using the posterior probability of an individual having a haplotype, given the genotype, in the context of generalized linear models. 18 Whenever linkage phase is unknown, the posterior probability is inferred by the EM algorithm, as described elsewhere. 19 This model allows the analysis of different kinds of traits, such as binomial, continuous or ordinal. In this study, we used two different approaches: for the outcomes diseased vs controls, the binomial model was employed, and for the ordinal outcome controls vs PB or MB, a proportional-odds model was used (Table 4) . In order to infer the strength of association, we also used the allele dose approach, using the allele postprobabilities calculated through the EM algorithm as the weights in a weighted logistic regression model. 18 This approach allowed us to calculate ORs for each haplotype studied and also allowed for the control of confounding variables. All the algorithms used and developed for this analysis were in the R environment. For abbreviations, see Table 3 footnote.
a Maximum overall P-value was 0.043.
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results do not yet provide a clear answer as to why À3575A/À2849G/À2763C is a protective and À3575T/ À2849A/À2763C a susceptible haplotype in leprosy. We expect lower IL-10 production in patients carrying the protective haplotype, while the carriers of the susceptible haplotype would produce higher IL-10 levels, but this is the subject of future study. Recently Mira et al 5 provided strong genetic evidence for the participation of parkin and parkin coregulated genes as major determinants in susceptibility of leprosy per se, while Miller et al 21 have suggested the participation of NOS2A. Thus, the interplay of IL-10 with other genes involved in controlling innate and acquired immunity needs to be studied in order to understand the genetics of complex traits in infectious diseases.
